Biological evaluation of 2-arylidene-4, 7-dimethyl indan-1-one (FXY-1): a novel Akt inhibitor with potent activity in lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2956-8
Published Online: 2016-01-18
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rajagopalan, Prasanna
Alahmari, Khalid A.
Elbessoumy, Ashraf A.
Balasubramaniam, Meenakshisundaram
Suresh, Radhakrishnan
Shariff, Mohammed Eajaz Ahmed
Chandramoorthy, Harish C.
Text and Data Mining valid from 2016-01-18